MetaVia begins patient dosing in Part 3 of phase 1 study of DA-1726, a GLP-1 and glucagon dual agonist to treat obesity: Cambridge, Massachusetts Monday, April 13, 2026, 11:00 Hrs ...
While protests draw attention to abuses, there remains only one true check on power: our right to vote.
Opioid dependence, characterized by high relapse rates and substantial social harm, represents a major global public health ...
A new USC-led study using functional magnetic resonance imaging (fMRI) reveals the neural mechanisms that contribute to ...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
In conversation with The Dallas Morning News, the Mavericks' governor discussed touched on lots of the biggest stories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results